These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

472 related items for PubMed ID: 17279300

  • 1. Combined ciprofloxacin and tinidazole therapy in the treatment of chronic refractory pouchitis.
    Shen B, Fazio VW, Remzi FH, Bennett AE, Lopez R, Brzezinski A, Oikonomou I, Sherman KK, Lashner BA.
    Dis Colon Rectum; 2007 Apr; 50(4):498-508. PubMed ID: 17279300
    [Abstract] [Full Text] [Related]

  • 2. Oral budesonide in the treatment of chronic refractory pouchitis.
    Gionchetti P, Rizzello F, Poggioli G, Pierangeli F, Laureti S, Morselli C, Tambasco R, Calabrese C, Campieri M.
    Aliment Pharmacol Ther; 2007 May 15; 25(10):1231-6. PubMed ID: 17451569
    [Abstract] [Full Text] [Related]

  • 3. Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice.
    Shen B, Brzezinski A, Fazio VW, Remzi FH, Achkar JP, Bennett AE, Sherman K, Lashner BA.
    Aliment Pharmacol Ther; 2005 Oct 15; 22(8):721-8. PubMed ID: 16197493
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis.
    Gosselink MP, Schouten WR, van Lieshout LM, Hop WC, Laman JD, Ruseler-van Embden JG.
    Dis Colon Rectum; 2004 Sep 15; 47(9):1519-25. PubMed ID: 15486751
    [Abstract] [Full Text] [Related]

  • 7. Rifaximin-ciprofloxacin combination therapy is effective in chronic active refractory pouchitis.
    Abdelrazeq AS, Kelly SM, Lund JN, Leveson SH.
    Colorectal Dis; 2005 Mar 15; 7(2):182-6. PubMed ID: 15720360
    [Abstract] [Full Text] [Related]

  • 8. Association between fecal hydrogen sulfide production and pouchitis.
    Ohge H, Furne JK, Springfield J, Rothenberger DA, Madoff RD, Levitt MD.
    Dis Colon Rectum; 2005 Mar 15; 48(3):469-75. PubMed ID: 15747080
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Topical tacrolimus therapy for antibiotic-refractory pouchitis.
    Uchino M, Ikeuchi H, Matsuoka H, Bando T, Hida N, Nakamura S, Takesue Y, Tomita N.
    Dis Colon Rectum; 2013 Oct 15; 56(10):1166-73. PubMed ID: 24022534
    [Abstract] [Full Text] [Related]

  • 11. Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.
    Hanauer SB, Sandborn WJ, Kornbluth A, Katz S, Safdi M, Woogen S, Regalli G, Yeh C, Smith-Hall N, Ajayi F.
    Am J Gastroenterol; 2005 Nov 15; 100(11):2478-85. PubMed ID: 16279903
    [Abstract] [Full Text] [Related]

  • 12. A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis.
    Safdi M, DeMicco M, Sninsky C, Banks P, Wruble L, Deren J, Koval G, Nichols T, Targan S, Fleishman C, Wiita B.
    Am J Gastroenterol; 1997 Oct 15; 92(10):1867-71. PubMed ID: 9382054
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comprehensive evaluation of inflammatory and noninflammatory sequelae of ileal pouch-anal anastomoses.
    Shen B, Fazio VW, Remzi FH, Delaney CP, Bennett AE, Achkar JP, Brzezinski A, Khandwala F, Liu W, Bambrick ML, Bast J, Lashner B.
    Am J Gastroenterol; 2005 Jan 15; 100(1):93-101. PubMed ID: 15654787
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Assessment of disease severity and outcome of dietary, antibiotic, and immunosuppressive interventions by use of the canine IBD activity index in 21 dogs with chronic inflammatory bowel disease].
    Münster M, Hörauf A, Bilzer T.
    Berl Munch Tierarztl Wochenschr; 2006 Jan 15; 119(11-12):493-505. PubMed ID: 17172138
    [Abstract] [Full Text] [Related]

  • 17. A randomized clinical trial of ciprofloxacin and metronidazole to treat acute pouchitis.
    Shen B, Achkar JP, Lashner BA, Ormsby AH, Remzi FH, Brzezinski A, Bevins CL, Bambrick ML, Seidner DL, Fazio VW.
    Inflamm Bowel Dis; 2001 Nov 15; 7(4):301-5. PubMed ID: 11720319
    [Abstract] [Full Text] [Related]

  • 18. A cost-effectiveness analysis of diagnostic strategies for symptomatic patients with ileal pouch-anal anastomosis.
    Shen B, Shermock KM, Fazio VW, Achkar JP, Brzezinski A, Bevins CL, Bambrick ML, Remzi FH, Lashner BA.
    Am J Gastroenterol; 2003 Nov 15; 98(11):2460-7. PubMed ID: 14638349
    [Abstract] [Full Text] [Related]

  • 19. Pros and cons of antibiotic therapy for pouchitis.
    Navaneethan U, Shen B.
    Expert Rev Gastroenterol Hepatol; 2009 Oct 15; 3(5):547-59. PubMed ID: 19817675
    [Abstract] [Full Text] [Related]

  • 20. Collagenous pouchitis.
    Shen B, Bennett AE, Fazio VW, Sherman KK, Sun J, Remzi FH, Lashner BA.
    Dig Liver Dis; 2006 Sep 15; 38(9):704-9. PubMed ID: 16807149
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.